Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy.

about

Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy.

Item

http://www.wikidata.org/entity/Q51736900

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Eslicarbazepine acetate in the ...... , safety and place in therapy.

@en

Eslicarbazepine acetate in the ...... , safety and place in therapy.

@nl

type

Item

label

Eslicarbazepine acetate in the ...... , safety and place in therapy.

@en

Eslicarbazepine acetate in the ...... , safety and place in therapy.

@nl

prefLabel

Eslicarbazepine acetate in the ...... , safety and place in therapy.

@en

Eslicarbazepine acetate in the ...... , safety and place in therapy.

@nl

P1476

Eslicarbazepine acetate in the ...... , safety and place in therapy.

@en

P2093

Alberto Verrotti

http://www.w3.org/2001/XMLSchema#string

Claudia Cagnetti

http://www.w3.org/2001/XMLSchema#string

Mauro Silvestrini

http://www.w3.org/2001/XMLSchema#string

Simona Lattanzi

http://www.w3.org/2001/XMLSchema#string

P2860

How common are the "common" neurologic disorders?

Pharmacokinetics and drug interactions of eslicarbazepine acetate.

Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.

Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action.

Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.

Real-world data on eslicarbazepine acetate as add-on to antiepileptic monotherapy

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcom

Transition from oxcarbazepine to eslicarbazepine acetate: A single center study.

Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.

P304

21-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CE.S142858

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Brigo

Gaetano Zaccara

P577

2018-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29563858

http://www.w3.org/2001/XMLSchema#string

P932

5846310

http://www.w3.org/2001/XMLSchema#string